Demand for Global Anticoagulants Market Size to Hit USD 42,756.02 Million by 2028, Exhibit a CAGR of 9.01% - Industry Trends, Share, Analysis & Forecast Report by Facts & Factors
August 01, 2022 12:26 ET
|
Facts & Factors
NEW YORK, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Anticoagulants Market Size, Share, Growth Analysis Report By Drug Class...
Anticoagulant Market Size to Worth Around US$ 70 Bn by 2030
June 13, 2022 11:00 ET
|
Precedence Research
Ottawa, June 13, 2022 (GLOBE NEWSWIRE) -- The global anticoagulants market size was valued at US$ 32 billion in 2021. COVID-19 pandemic is foreseen to have a noticeable impact on the anticoagulant...
Anticoagulants Market Size Worth 65.44 Billion, Globally, by 2031 at 7.3% CAGR: Growth Plus Reports
June 08, 2022 07:33 ET
|
Growth Plus Reports
Pune, June 08, 2022 (GLOBE NEWSWIRE) -- The Global Anticoagulants Market is expected to clock US$ ~65.44 billion by 2031 owing to the rising prevalence of deep vein thrombosis (DVT) & atrial...
Anticoagulants Market Size [2019-2026] worth USD 45.50 Billion | Exhibit a CAGR of 9.9%
March 07, 2022 02:05 ET
|
Fortune Business Insights
Pune, India, March 07, 2022 (GLOBE NEWSWIRE) -- The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business...
Anticoagulants Market to reach USD 45.50 Billion by 2026 Driven by the Emphasis on R&D of Associated Drugs, says Fortune Business Insights
December 19, 2019 08:36 ET
|
Fortune Business Insights
Pune, Dec. 19, 2019 (GLOBE NEWSWIRE) -- The global Anticoagulants Market size is projected to reach USD 45.50 billion by the end of 2026. According to a report published by Fortune Business...
Global Anticoagulants Market Will Reach USD 43.6 Billion By 2025: Zion Market Research
March 18, 2019 08:07 ET
|
Zion Market Research
New York, NY, March 18, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Anticoagulants Market by Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and...